This study is currently not recruiting participants.

Clinical Trial Protocol for the iCubate iC-GN Assay from Positive Blood Cultures: (iC-MDC-2017-001)

Investigation of Diagnostic Assay for Gram-Negative Infections

Not Recruiting
100 years or below
All
Phase N/A

Brief description of study.

The purpose of this study is to evaluate the performance of the iCubate Gram Negative (iC-GN) Assay in a clinical setting.

Detailed description of study

The purpose of this study is to evaluate the performance of the iCubate Gram Negative (iC-GN) Assay in a clinical setting.

Eligibility of study

You may be eligible for this study if you meet the following criteria:

  • Conditions: Healthy
  • Age: 100 years or below
  • Gender: All

The purpose of this study is to investigate the performance of a diagnostic test for identifying gram-negative bacterial infections in a clinical setting. Gram-negative bacteria are a type of bacteria that can cause infections and are characterized by their cell wall structure, which makes them resistant to some antibiotics.

Participants in this study will undergo testing using the diagnostic assay. The procedures involve collecting samples, which will be analyzed to assess the assay's effectiveness in detecting gram-negative bacteria.

  • Who can participate: Participants must meet specific eligibility criteria, including being adults aged 18 or older. Additional eligibility factors may include having symptoms of a gram-negative bacterial infection or being at risk for such infections.
  • Study details: Participants will provide samples that will be tested using the investigational diagnostic assay. The study does not involve any treatment, and participants are not required to take any medication.
Updated on 19 Feb 2024. Study ID: 1809286430

Interested in the study?

Select a study center that’s convenient for you, and get in touch with the study team.

Connect with the study team